China Transdermal Scopolamine Market Research Report 2018

February 2018 | 98 pages | ID: CE098660A57EN
QYResearch

Abstracts

The global Transdermal Scopolamine market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Transdermal Scopolamine development status and future trend in China, focuses on top players in China, also splits Transdermal Scopolamine by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Baxter International Inc.
• GlaxoSmithKline plc
• Novartis AG
• Perrigo Company plc.
• Caleb Pharmaceuticals, Inc.
• Myungmoon Pharma Co. LTD.

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (Units), revenue (Million USD), product price (K USD/Unit), market share and growth rate of each type, primarily split into

• Tablet Type
• Syrups Type
• Injections Type
• Patch Type
• Gel Type

On the basis of the end users/application, this report covers

• Hospital
• Clinic
• Ambulance Center
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Transdermal Scopolamine Market Research Report 2017

1 TRANSDERMAL SCOPOLAMINE OVERVIEW

1.1 Product Overview and Scope of Transdermal Scopolamine
1.2 Classification of Transdermal Scopolamine by Product Category
  1.2.1 China Transdermal Scopolamine Sales (Units) Comparison by Type (2012-2022)
  1.2.2 China Transdermal Scopolamine Sales (Units) Market Share by Type in 2016
  1.2.3 Tablet Type
  1.2.4 Syrups Type
  1.2.5 Injections Type
  1.2.6 Patch Type
  1.2.7 Gel Type
1.3 China Transdermal Scopolamine Market by Application/End Users
  1.3.1 China Transdermal Scopolamine Sales (Units) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Ambulance Center
  1.3.5 Others
1.4 China Transdermal Scopolamine Market by Region
  1.4.1 China Transdermal Scopolamine Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.3 East China Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.4 Southwest China Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.5 Northeast China Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.6 North China Transdermal Scopolamine Status and Prospect (2012-2022)
  1.4.7 Central China Transdermal Scopolamine Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Transdermal Scopolamine (2012-2022)
  1.5.1 China Transdermal Scopolamine Sales (Units) and Growth Rate (%)(2012-2022)
  1.5.2 China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA TRANSDERMAL SCOPOLAMINE MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Transdermal Scopolamine Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Transdermal Scopolamine Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Transdermal Scopolamine Average Price (K USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Transdermal Scopolamine Market Competitive Situation and Trends
  2.4.1 China Transdermal Scopolamine Market Concentration Rate
  2.4.2 China Transdermal Scopolamine Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Transdermal Scopolamine Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA TRANSDERMAL SCOPOLAMINE SALES AND REVENUE BY REGION (2012-2017)

3.1 China Transdermal Scopolamine Sales (Units) and Market Share by Region (2012-2017)
3.2 China Transdermal Scopolamine Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Transdermal Scopolamine Price (K USD/Unit) by Regions (2012-2017)

4 CHINA '&B1&' SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)'

4.1 China Transdermal Scopolamine Sales (Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Transdermal Scopolamine Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Transdermal Scopolamine Price (K USD/Unit) by Type (2012-2017)
4.4 China Transdermal Scopolamine Sales Growth Rate (%) by Type (2012-2017)

5 CHINA '&B1&' SALES BY APPLICATION (2012-2017)'

5.1 China Transdermal Scopolamine Sales (Units) and Market Share by Application (2012-2017)
5.2 China Transdermal Scopolamine Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA TRANSDERMAL SCOPOLAMINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Baxter International Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Transdermal Scopolamine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter International Inc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline plc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Transdermal Scopolamine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline plc Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis AG
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Transdermal Scopolamine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis AG Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Perrigo Company plc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Transdermal Scopolamine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Perrigo Company plc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Caleb Pharmaceuticals, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Transdermal Scopolamine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Myungmoon Pharma Co. LTD.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Transdermal Scopolamine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview

7 TRANSDERMAL SCOPOLAMINE MANUFACTURING COST ANALYSIS

7.1 Transdermal Scopolamine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transdermal Scopolamine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Transdermal Scopolamine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transdermal Scopolamine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA TRANSDERMAL SCOPOLAMINE MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Transdermal Scopolamine Sales (Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Transdermal Scopolamine Sales (Units) Forecast by Type (2017-2022)
11.3 China Transdermal Scopolamine Sales (Units) Forecast by Application (2017-2022)
11.4 China Transdermal Scopolamine Sales (Units) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Transdermal Scopolamine Sales (Units) and Revenue (Million USD) Market Split by Product Type
Table Transdermal Scopolamine Sales (Units) by Application (2016-2022)
Figure Product Picture of Transdermal Scopolamine
Table China Transdermal Scopolamine Sales (Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Transdermal Scopolamine Sales Volume Market Share by Types in 2016
Figure Tablet Type Product Picture
Figure Syrups Type Product Picture
Figure Injections Type Product Picture
Figure Patch Type Product Picture
Figure Gel Type Product Picture
Figure China Transdermal Scopolamine Sales (Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Transdermal Scopolamine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Ambulance Center Examples
Table Key Downstream Customer in Ambulance Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Transdermal Scopolamine Sales (Units) and Growth Rate (%)(2012-2022)
Figure China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Transdermal Scopolamine Sales of Key Players/Manufacturers (2012-2017)
Table China Transdermal Scopolamine Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Transdermal Scopolamine Sales Share (%) by Players/Manufacturers
Figure 2017 China Transdermal Scopolamine Sales Share (%) by Players/Manufacturers
Table China Transdermal Scopolamine Revenue by Players/Manufacturers (2012-2017)
Table China Transdermal Scopolamine Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Transdermal Scopolamine Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Transdermal Scopolamine Revenue Market Share (%) by Players/Manufacturers
Table China Market Transdermal Scopolamine Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Transdermal Scopolamine Average Price of Key Players/Manufacturers in 2016
Figure China Transdermal Scopolamine Market Share of Top 3 Players/Manufacturers
Figure China Transdermal Scopolamine Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Transdermal Scopolamine Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Transdermal Scopolamine Product Category
Table China Transdermal Scopolamine Sales (Units) by Regions (2012-2017)
Table China Transdermal Scopolamine Sales Share (%) by Regions (2012-2017)
Figure China Transdermal Scopolamine Sales Share (%) by Regions (2012-2017)
Figure China Transdermal Scopolamine Sales Market Share (%) by Regions in 2016
Table China Transdermal Scopolamine Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Transdermal Scopolamine Revenue Market Share (%) by Regions (2012-2017)
Figure China Transdermal Scopolamine Revenue Market Share (%) by Regions (2012-2017)
Figure China Transdermal Scopolamine Revenue Market Share (%) by Regions in 2016
Table China Transdermal Scopolamine Price (K USD/Unit) by Regions (2012-2017)
Table China Transdermal Scopolamine Sales (Units) by Type (2012-2017)
Table China Transdermal Scopolamine Sales Share (%) by Type (2012-2017)
Figure China Transdermal Scopolamine Sales Share (%) by Type (2012-2017)
Figure China Transdermal Scopolamine Sales Market Share (%) by Type in 2016
Table China Transdermal Scopolamine Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Transdermal Scopolamine Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Transdermal Scopolamine by Type (2012-2017)
Figure Revenue Market Share of Transdermal Scopolamine by Type in 2016
Table China Transdermal Scopolamine Price (K USD/Unit) by Types (2012-2017)
Figure China Transdermal Scopolamine Sales Growth Rate (%) by Type (2012-2017)
Table China Transdermal Scopolamine Sales (Units) by Applications (2012-2017)
Table China Transdermal Scopolamine Sales Market Share (%) by Applications (2012-2017)
Figure China Transdermal Scopolamine Sales Market Share (%) by Application (2012-2017)
Figure China Transdermal Scopolamine Sales Market Share (%) by Application in 2016
Table China Transdermal Scopolamine Sales Growth Rate (%) by Application (2012-2017)
Figure China Transdermal Scopolamine Sales Growth Rate (%) by Application (2012-2017)
Table Baxter International Inc. Transdermal Scopolamine Basic Information List
Table Baxter International Inc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Baxter International Inc. Transdermal Scopolamine Sales (Units) and Growth Rate (%)(2012-2017)
Figure Baxter International Inc. Transdermal Scopolamine Sales Market Share (%) in China (2012-2017)
Figure Baxter International Inc. Transdermal Scopolamine Revenue Market Share (%) in China (2012-2017)
Table GlaxoSmithKline plc Transdermal Scopolamine Basic Information List
Table GlaxoSmithKline plc Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline plc Transdermal Scopolamine Sales (Units) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline plc Transdermal Scopolamine Sales Market Share (%) in China (2012-2017)
Figure GlaxoSmithKline plc Transdermal Scopolamine Revenue Market Share (%) in China (2012-2017)
Table Novartis AG Transdermal Scopolamine Basic Information List
Table Novartis AG Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Novartis AG Transdermal Scopolamine Sales (Units) and Growth Rate (%)(2012-2017)
Figure Novartis AG Transdermal Scopolamine Sales Market Share (%) in China (2012-2017)
Figure Novartis AG Transdermal Scopolamine Revenue Market Share (%) in China (2012-2017)
Table Perrigo Company plc. Transdermal Scopolamine Basic Information List
Table Perrigo Company plc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Perrigo Company plc. Transdermal Scopolamine Sales (Units) and Growth Rate (%)(2012-2017)
Figure Perrigo Company plc. Transdermal Scopolamine Sales Market Share (%) in China (2012-2017)
Figure Perrigo Company plc. Transdermal Scopolamine Revenue Market Share (%) in China (2012-2017)
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Basic Information List
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales (Units) and Growth Rate (%)(2012-2017)
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales Market Share (%) in China (2012-2017)
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Revenue Market Share (%) in China (2012-2017)
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Basic Information List
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (%)(2012-2017)
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales (Units) and Growth Rate (%)(2012-2017)
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales Market Share (%) in China (2012-2017)
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Scopolamine
Figure Manufacturing Process Analysis of Transdermal Scopolamine
Figure Transdermal Scopolamine Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Scopolamine Major Players/Manufacturers in 2016
Table Major Buyers of Transdermal Scopolamine
Table Distributors/Traders List
Figure China Transdermal Scopolamine Sales (Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Transdermal Scopolamine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Transdermal Scopolamine Price (K USD/Unit) Trend Forecast (2017-2022)
Table China Transdermal Scopolamine Sales (Units) Forecast by Type (2017-2022)
Figure China Transdermal Scopolamine Sales (Units) Forecast by Type (2017-2022)
Figure China Transdermal Scopolamine Sales Volume Market Share Forecast by Type in 2022
Table China Transdermal Scopolamine Sales (Units) Forecast by Application (2017-2022)
Figure China Transdermal Scopolamine Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Transdermal Scopolamine Sales Volume Market Share Forecast by Application in 2022
Table China Transdermal Scopolamine Sales (Units) Forecast by Regions (2017-2022)
Table China Transdermal Scopolamine Sales Volume Share Forecast by Regions (2017-2022)
Figure China Transdermal Scopolamine Sales Volume Share Forecast by Regions (2017-2022)
Figure China Transdermal Scopolamine Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources